chrisvoncsefalvay/vaers-outcomes huggingface dataset:
cough; This spontaneous case was reported by a nurse and describes the occurrence of COUGH (cough) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 0171B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Mar-2021, the patient experienced COUGH (cough). At the time of the report, COUGH (cough) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported.   No corrective treatment was provided.   Reporter did not allow further contact
Severe body, neck and joint pain.  Stomach cramps,  headache, fever reach 101.8, vertigo, face and lips felt numb, absolute exhaustion. These symptoms lasted for 48 hours although the worst of it was the first 24.   Many of the same symptoms we the same I had with Covid in November -December 2020.   I did not, however experience sore throat or congestion.
Bloody discharge thru left nipple.  Sonomammography, mammography with Tomosintesis, Biopsy, and MRI with contrast all show solid intraductal mass.   Have bern referred to oncological  surgeon for full removal and confirmatory biopsy.  Continue to bleed ocassionsllyvsnd pain.
Pain, limited range of motion (inability to lift arm in motion to take shirt off over head, or move arm to the right).
01/15/21; I had high blood pressure and went to see my doctor. I went in because I was having a really bad headache, I actually went for a routine office visit with my PCP and my blood pressure was 200/120. I had a massive headache and my doctor sent me to get acute care and they did a CT scan of the head which was unremarkable. They kept me there and gave me medicine to get my headache down. 01/16/2021; I ended up at an urgent care because I felt I could not breathe and my blood pressure was really high 240/140. They again gave me blood pressure medicine. On 01/19/2021; I felt ill all day and later that night my hands locked up my hands went into spasms and I again had horrible pain. An ambulance was called and they took me to the Hospital. They said my D-dimmer was high, they also did an angio full body CT and found two blood clots in my lungs. I was back at the ER 2 days later with chest pain and 2 days after that I had a DVT on my legs and the doctors put me Eloquist. I also went through hematology and cardiology and wore a holster monitor but the doctors did not see that I was predisposed or had any heart issues so they decided to take me off of the Eloquist medication. I have not recovered of my symptoms.
Patient experience syncopal episode around 7pm after receiving the COVID-19 vaccine at 11:22 am the same day.  Patient then experienced a second syncopal episode sometime through the night and EMS was call to bring patient to the ER.  Patient reported headache, generalized weakness, and malaise.  Patient was later admitted to the hospital for monitoring of vitals, neuro checks and anti-emetics.
pea size swelling at injection site; Wallnut size swelling at injection site; This spontaneous information has been received from a charge nurse via company representative, concerning a female patient of unknown age. The patient's medical history, concurrent conditions, previously drug reactions, allergies and concomitant medications were unknown by the reporter.  On an unspecified date, the patient was vaccinated with her first dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) as prophylaxis (reported as to prevent human papillomavirus (HPV)) (strength, route of administration, lot number and expiration date were unknown) and developed a pea size swelling at injection site (vaccination site swelling).  On an unspecified date in October 2019 (reported as this week), the patient received her second dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) as prophylaxis (reported as to prevent human papillomavirus (HPV)) (strength, route of administration, lot number and expiration date were unknown) and developed walnut sized swelling at injection site. The nurse reported that the swelling resolved within 48 hours. The patient did not seek for medical attention and no treatment was given for the vaccination site swellings. It was unknown if lab diagnostics or studies were performed.  The causal relationship between the vaccination site swelling and the hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) was not provided.
Pfizer on 4/19 and 5/10. Positive on 9/11
Patient was admitted to the hospital due to chest pain and shortness of breath. Was found with right pulmonary arterial emboli on CT chest angiogram. Started therapeutic dose of Lovenox, and now switched to apixaban. Symptoms improved, still hospitalized today. No DVT was found in lower extremities. Echocardiogram showed no RV strain with normal LV function and size. EF 65%.
fever following day, clingy, vomited x1 day after vaccination, now with runny nose suspicious for URI
localized redness and swelling below injection site 1 hour following vaccination and continuing following application of ice pack
Later that day Dec 5, 2017 after the vaccination it becomes sore and the pain got worse as the day went by. On Dec 11, 2017 she pass by the pharmacy because she was still in pain on the injection site and bothers her so I told her to put a cold compress which she did for an hour and the pain was gone. Today, 12/13/2017 I called her to check on her and told me everything is okay after she put cold compress.
pt recv vax 22FEB96 & 12MAR96 seen high fever 104,nasal congestion 5-6 days;CBC blood cult;rash noted 2MAR96;lethargy persistent,fever;fever broke 4MAR96;
Systemic: Vomiting-Mild, Additional Details: patient passed out for about a minute, vomitting, pale looking, was able to wake up right away, was instructed to take deep breath, drink some water, was obsered for 15 minutes then sit up for 10 minutes before walk away.
Soreness at injection site (L) arm. Swollen from elbow to shoulder. Warm to touch. Symptoms lasted for 2 days.
dizziness; blurred vision; sore throat; Drop in blood pressure; tiredness; could not lift her arms; lymph nodes swollen; right shoulder hurt; arms, neck hurt/painful; arms, neck hurt/painful; diarrhea; Weakness; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizziness), VISION BLURRED (blurred vision), OROPHARYNGEAL PAIN (sore throat), BLOOD PRESSURE DECREASED (Drop in blood pressure) and ASTHENIA (Weakness) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Lumpectomy. Concurrent medical conditions included Drug allergy (phenylephrine.).    On 20-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Mar-2021, the patient experienced ASTHENIA (Weakness). On 23-Mar-2021, the patient experienced DIARRHOEA (diarrhea). On 25-Mar-2021, the patient experienced NECK PAIN (arms, neck hurt/painful), MYALGIA (arms, neck hurt/painful) and ARTHRALGIA (right shoulder hurt). On 27-Mar-2021, the patient experienced MOBILITY DECREASED (could not lift her arms) and LYMPHADENOPATHY (lymph nodes swollen). On an unknown date, the patient experienced DIZZINESS (dizziness), VISION BLURRED (blurred vision), OROPHARYNGEAL PAIN (sore throat), BLOOD PRESSURE DECREASED (Drop in blood pressure) and FATIGUE (tiredness). At the time of the report, DIZZINESS (dizziness), VISION BLURRED (blurred vision), OROPHARYNGEAL PAIN (sore throat), BLOOD PRESSURE DECREASED (Drop in blood pressure), ASTHENIA (Weakness), FATIGUE (tiredness), DIARRHOEA (diarrhea), NECK PAIN (arms, neck hurt/painful), MYALGIA (arms, neck hurt/painful), MOBILITY DECREASED (could not lift her arms), LYMPHADENOPATHY (lymph nodes swollen) and ARTHRALGIA (right shoulder hurt) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood glucose: normal (normal) Normal. On an unknown date, Electrocardiogram: normal (normal) Normal.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication details was reported. Treatment medication included as water.   Most recent FOLLOW-UP information incorporated above includes: On 30-Mar-2021: Significant follow up appended
Patient came in on 5/7 for 2nd dose. During this appt she stated that when she received the 1st dose she felt dizzy and her lips a little tingly. Patient was advised she would have to sit for 30 minutes after receiving 2nd dose.  Within the 30 minutes of patient receiving her 2nd dose, she stated that her lips and tongue were tingly again. We got patient water and advised to take Benadryl we had on hand however patient stated she could not take Benadryl but she had Zyrtec. Consulted with Dr. who advised Zyrtec was fine. Patient took medication and sat for an additional 20 minutes. Stated that the tingling in her mouth/lips had subsided almost 100%.
12 hours after vaccine administration developed arthralgia, myalgia, mild fever, stomach queeziness.  Nearly 1 month later, developed arthralgia, myalgia, mild fever, stomach queeziness.
I awakened finding myself itching on my right breast. It was slightly swollen. I also had three small hive looking places just below my rib cage.  At that point I decided to take a Benadryl, waited five minutes and noticed I now had three small hive looking places on my right rib cage. So I took another Benadryl and within 5/10 minutes the itching faded. Everything seem to be under control so I went back to sleep. Upon awakening in the morning there were no more signs of hives and I had no further symptoms. The injection  site was never any problem.
administering an expired pentacel to a patient with no reported adverse event; Initial information received on 12-Oct-2023 regarding an unsolicited valid  non-serious case received from a other health professional.  This case involves a patient of an unknown age and gender, reporter reported that the an expired diphtheria/tetanus/5 Hybrid Ac Pertussis/IPV(Vero)/HIB(PRP/T) Vaccine [Pentacel (Vero)] administering  to a patient with no reported adverse event.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On 11-Oct-2023, the patient received a expired dose of 0.5 ml of suspect diphtheria/tetanus/5 Hybrid Ac Pertussis/IPV(Vero)/HIB(PRP/T) Vaccine Suspension for injection (strength: standard, frequency: once, expiry date: 08-Oct-2023 and lot UJ794AB) via unknown route in unknown administration site as immunization (expired product administered) (same day latency).  Action taken: not applicable.  At time of reporting, the outcome was Unknown for the event.   This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  No additional information available at time of call; caller declined to respond to questions and refuses future follow-up.
pain like beesting at time of injection; redness; Sore arm; Swelling on injection site; This spontaneous case was reported by a patient and describes the occurrence of INJECTION SITE PAIN (pain like beesting at time of injection), PAIN IN EXTREMITY (Sore arm), ERYTHEMA (redness) and INJECTION SITE SWELLING (Swelling on injection site) in a 78-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 037B20A and 041L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.   On 25-Jan-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Jan-2021, the patient experienced PAIN IN EXTREMITY (Sore arm). On an unknown date, the patient experienced INJECTION SITE PAIN (pain like beesting at time of injection). an unknown date, the patient experienced ERYTHEMA (redness) and INJECTION SITE SWELLING (Swelling on injection site). The patient was treated with IBUPROFEN at a dose of unkown. At the time of the report, INJECTION SITE PAIN (pain like beesting at time of injection), PAIN IN EXTREMITY (Sore arm), ERYTHEMA (redness) and INJECTION SITE SWELLING (Swelling on injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) and mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication was not provided. Treatment includes cold compress and then reaction subsided.   Reporter did not allow further contact
This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm pain) and ARTHRALGIA (shoulder area pain) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (arm pain) and ARTHRALGIA (shoulder area pain). At the time of the report, PAIN IN EXTREMITY (arm pain) and ARTHRALGIA (shoulder area pain) outcome was unknown. Unknown. Action taken with mRNA-1273 in response to the drug was not applicable. No concomitant medication information was provided. No treatment products information was provided. Reporter did not allow further contact.
Per patient after receiving flu shot her right side of face lost the sense (numb like). When again call on 11-8-10 she is feeling much better.
Flu like symptoms 5 days after last tablet.  Fever x 4 days.  Nausea x 2 weeks.
Patient got her first SHINGRIX vaccine at pharmacy approximately 6 months ago prior to coming here for her second dose on 3/7/19. She told me that when she got her first shot at pharmacy, the pain/redness disappeared about one week. After receiving her second vaccine shot by the staff pharmacist, she has been experiencing redness, swelling, and itching for a little over 3 weeks. She did not see a doctor or use any medications to help treat her symptoms after 3/7/19. She was given Hydrocortisone 1% cream with Aloe on 3/30/19 when she came into the store after speaking about her symptoms. She has been using the OTC medication for the past several days and since 4/2/19, the swelling/itching has subsided, the redness slightly got lighter, but she still states that she is still tender at the injection site. It seems like her symptoms have been improving after using the Hydrocortisone 1% cream w/Aloe.
This spontaneous report as received from a registered nurse refers to an 83 year old female patient. The patient's medical history included "vasectomy". On 11-DEC-2012, the patient was vaccinated with a 0.65 ml dose of ZOSTAVAX (route and lot # not reported). The nurse reported that on 19-DEC-2012, the patient was diagnosed with shingles. The patient was seen in the physician's office for treatment on three separate occasions after 19-DEC-2012, the patient was diagnosed with shingles. The patient was seen in the physician's office for treatment on three separate occasions after 19-DEC-2012. The nurse described that the shingles outbreak was on the trunk area of the patient's body. The nurse explained that the physician believed the outbreak to be the result of a change in the brand of the undergarment the patient used (brand unspecified). The nurse stated that the patient suffered no long term effects after "about three months" after she was diagnosed with shingles. The patient was treated with unspecified pain medication. There were no Lab diagnosis or studies performed. The outcome of shingles was unknown. Additional information has been requested.
Patient tested positive for Covid on 2/2/2022.  Was given Paxlovid for treatment but did not take.   Was taken to ED via Emergency transport due to fall. left knee pain, and fall.  Unrelated to COVID positive.
Moderna vaccine given on 4/3/2023: vaccine expired on 3/30/2023: no adverse reactions noted: vaccine just was expired
day after- feet and hands swelled up (edema), edema kept getting worse and worse, saw PCP in June- pcp (retired PCP) noticed edema in feet, continued to worsen (feet completely discolored, skin was red and purple, rash like appearance, very itchy) got to point where couln't walk - edema was so bad and painful First went to Urgent care (no results) then went to ER ( 4 weeks ago) ER - diagnosed she has multiple blood clots, EKG- normal
I got COVID-19. I had chills for about 3 days then I had brain fog and memory loss and difficulty finding words. I went to the doctor and they said had paresthesia and neuropathy in arms and legs and it was intense pain. I also had nausea and upset stomach. I had bruising splotchy skin. I had salt cravings, edema, and I and a mood shift. I was anxious, irritable, and depressed.
This spontaneous case was reported by a consumer and describes the occurrence of RASH MACULAR (Delayed reaction red spot), INFECTION (infection), SWELLING (Delayed reaction swelling), PRURITUS (Delayed reaction itching) and PAIN (Delayed reaction pain) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Feb-2021, the patient experienced RASH MACULAR (Delayed reaction red spot), SWELLING (Delayed reaction swelling), PRURITUS (Delayed reaction itching) and PAIN (Delayed reaction pain). On 14-Feb-2021, the patient experienced INFECTION (infection). The patient was treated with CEFALEXIN (CEPHALEXINE) (oral) at a dose of 500 mg. At the time of the report, RASH MACULAR (Delayed reaction red spot), INFECTION (infection), SWELLING (Delayed reaction swelling), PRURITUS (Delayed reaction itching) and PAIN (Delayed reaction pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Blood Pressure began to spike in July. Due date 8/3/2021 but C-section is scheduled for 8/20. I have a history of pre-eclampsia. Nifedepine dose has been increased 3 times, I am currently on 120mg and my diastolic number remains in the high 90's and my OB continues to monitor me.
A non-serious spontaneous report of sinus infection has been received from a female consumer concerning herself, subsequent to FLUMIST. Neither relevant past medical history nor concomitant medications had been reported for this patient. The patient received FLUMIST on 23-Sep-2011. After receiving FLUMIST, the patient developed sinus infection which was confirmed by a physician on 06-Oct-2011. The symptoms were mild and no fever was developed. The outcome of the event of sinus infection was not provided.
About one week after getting the Covid vaccine I started to experience menstrual spotting. I have never experienced spotting in my life prior to getting the vaccine. I track my cycle on an app and this spotting occurred 2-3 week before I am expected to get my period. This was a very noticeable side effect and something I?ve never experienced outside of getting the vaccine.
raised area about 4 inches wide at injection site; itchy; red; joint pain; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (itchy), VACCINATION SITE ERYTHEMA (red), ARTHRALGIA (joint pain) and VACCINATION SITE SWELLING (raised area about 4 inches wide at injection site) in a 20-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Apr-2021, the patient experienced VACCINATION SITE PRURITUS (itchy), VACCINATION SITE ERYTHEMA (red) and ARTHRALGIA (joint pain). On an unknown date, the patient experienced VACCINATION SITE SWELLING (raised area about 4 inches wide at injection site). At the time of the report, VACCINATION SITE PRURITUS (itchy), VACCINATION SITE ERYTHEMA (red), ARTHRALGIA (joint pain) and VACCINATION SITE SWELLING (raised area about 4 inches wide at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication were reported.  Treatment information not provided.
Dizziness; Blurry vision; Nausea; Chills; This is a spontaneous report from a non-contactable consumer, the patient. A 32-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 10Jun2021 at 13:30 (at the age of 32-years-old) as a single dose for COVID-19 immunisation. Medical history included diabetes and polycystic ovary syndrome (PCOS). The patient had no known allergies. Concomitant medications included metformin (MANUFACTURER UNKNOWN) and melatonin (MANUFACTURER UNKNOWN); both from unknown date for unknown indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 10Jun2021 at 13:45, the patient experienced dizziness with blurry vision, nausea, and chills burst within 1 hour after first dose. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the events dizziness, blurry vision, nausea and chills was unknown at the time of this report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Pt woke at 0200 on 7/26/18 with vomiting x 7. Then again at 0730 x 5 had emesis. Top lip swollen. No tongue swelling, no SOB, No wheeze, No chest tightness, No rash. The injection site was without induration, redness, swelling, no rash. Pt stated it was tender to touch. No fever-but possible low grade fever per mom. Mom called with sx and also explained she gave Benedryl 25mg x 1 by mouth at 0800. Pt had a banana and water with Benedryl admin. Reviewed with mom signs and sx of what to watch for for indication to go to ER. Mom verbalized understanding and was comfortable with plan. Apply cool wash cloth to lips and monitor for any changes in swelling, breathing problems. Mom then called back at 1030 explaining that his eye was starting to swell, hand another episode of vomiting from water ingestion and was worried about dehydration. At this point the pt still without sx of tongue swelling or any breathing concerns. Employee spoke to mom --encouraged to go to ER if worried. Mom comfortable with waiting. Around 11am mom called stating she is taking to ER now because of throat feeling itchy. Employee went to ER to check on pt and he was given a dose of Decadron and Phenergan--released in stable condition. R.N.